Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious disease update: new anti-microbials.

Aparche Yang1, Francisco A Kerdel

  • 1Dermatology Resident, Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, FL 33136, USA.

Seminars in Cutaneous Medicine and Surgery
|August 16, 2006
PubMed
Summary

New antibacterial and antifungal drugs approved in the last 4 years offer hope against rising antimicrobial resistance. This review details FDA-approved treatments for skin infections, addressing a critical medical need.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare Presentation of TEN-Like Subacute Cutaneous Lupus Erythematosus Occurring in the Setting of Donepezil Exposure and COVID-19 Infection: A Diagnostic Challenge.

Journal of cutaneous pathology·2026
Same author

Erosive pustular dermatosis after CO<sub>2</sub> laser resurfacing in mother and daughter.

Dermatologic therapy·2020
Same author

Emerging drugs for the treatment of hidradenitis suppurativa.

Expert opinion on emerging drugs·2020
Same author

Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials.

Journal of drugs in dermatology : JDD·2018
Same author

A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis.

The Journal of dermatological treatment·2018
Same author

Scoring With SCORTEN-Reply.

Archives of dermatology·2017

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Pharmacology

Background:

  • Skin and skin structure infections are common medical conditions.
  • Antimicrobial resistance in bacteria, fungi, and parasites poses a significant challenge to treatment.
  • Novel antimicrobial development is crucial to combat resistance and manage infections effectively.

Purpose of the Study:

  • To review novel antibacterial and antifungal agents approved by the U.S. Food and Drug Administration (FDA) within the past four years.
  • To provide an overview of new therapeutic options for skin and skin structure infections.

Main Methods:

  • Literature search of FDA-approved antimicrobials.
  • Focus on agents approved in the last four years.
  • Categorization of drugs into antibacterials and antifungals.

Related Experiment Videos

Main Results:

  • Identification of specific novel antibacterial agents approved.
  • Identification of specific novel antifungal agents approved.
  • Summary of the therapeutic indications and spectrum of activity for these new drugs.

Conclusions:

  • The past four years have seen the approval of new antibacterials and antifungals.
  • These novel agents represent important advancements in combating antimicrobial resistance.
  • The reviewed drugs offer new treatment strategies for skin and skin structure infections.